公开(公告)号：US20240368176A1

公开(公告)日：2024-11-07

申请号：US18647107

申请日：2024-04-26

Applicant: Enanta Pharmaceuticals, Inc.

Inventor： Adam SZYMANIAK ,  Kevin McGRATH ,  Jianming YU ,  Tyler J. MANN ,  Long NGUYEN ,  Kaicheng ZHU ,  In Jong KIM ,  Yat Sun OR

IPC: C07D491/052 ,  C07D471/04 ,  C07D491/044 ,  C07D491/048

Abstract: The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof which inhibit Human Respiratory Syncytial Virus (HRSV) or Human Metapneumovirus (HMPV) inhibitors. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HRSV or HMPV infection. The invention also relates to methods of treating an HRSV or HMPV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.